“…This, in turn, results in proliferative disease, which accelerates the lupus-like disease (Drappa et al, 1993). Lack of tolerance also happens in non-autoimmune mice that (i) have a mutation leading to hyperreactive external calcium entry in B-cells (Yu et al, 2005), (ii) are overexpressing B-cell activators, including BAFF (Mackay et al, 1999), or (iii) are deficient (knockout) in inhibitors, including CD22 (Nitschke et al, 1997;O'Keefe et al, 1996;Otipoby et al, 1996;Sato et al, 1996), Lyn (Hibbs et al, 1995;Lamagna et al, 2013Lamagna et al, , 2014 and Fcc RIIb (Bolland & Ravetch, 2000). Similarly, we suggest that insertional mutagenesis may accelerate lupus in B/W mice.…”